RAD51 and XRCC2 Genetics Variants and Multiple Myeloma Risk, Chromosomal Aberrations, and Clinical Outcomes
The Application of Clinical Genetics · 2026-11 · Volume 19 · 1-17
DOI: 10.2147/tacg.s601102 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Application of Clinical Genetics, 2026-11. Verfasst von Sylwia Popek-Marciniec und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Popek-Marciniec, S., Styk, W., Sienkiewicz, K., Chocholska, S., Szudy-Szczyrek, A., Hus, M., Czerwik-Marcinkowska, J., Świderska-Kołacz, G., Pietras, T., & Zmorzyński, S. (2026). RAD51 and XRCC2 Genetics Variants and Multiple Myeloma Risk, Chromosomal Aberrations, and Clinical Outcomes. The Application of Clinical Genetics, Volume 19, 1-17. https://doi.org/10.2147/tacg.s601102
Vancouver
Popek-Marciniec S, Styk W, Sienkiewicz K, Chocholska S, Szudy-Szczyrek A, Hus M, et al. RAD51 and XRCC2 Genetics Variants and Multiple Myeloma Risk, Chromosomal Aberrations, and Clinical Outcomes. The Application of Clinical Genetics. 2026;Volume 19:1-17. doi:10.2147/tacg.s601102
BibTeX
@article{PopekMarciniec2026,
author = {Popek-Marciniec, Sylwia and Styk, Wojciech and Sienkiewicz, Kinga and Chocholska, Sylwia and Szudy-Szczyrek, Aneta and Hus, Marek and Czerwik-Marcinkowska, Joanna and Świderska-Kołacz, Grażyna and Pietras, Tadeusz and Zmorzyński, Szymon},
title = {RAD51 and XRCC2 Genetics Variants and Multiple Myeloma Risk, Chromosomal Aberrations, and Clinical Outcomes},
journal = {The Application of Clinical Genetics},
year = {2026},
volume = {Volume 19},
pages = {1--17},
doi = {10.2147/tacg.s601102}
}
EUVIMED